Assessment of the risk of cyclosporiasis importation into China

CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES ›› 2026, Vol. 44 ›› Issue (4): 517-524.doi: 10.12140/j.issn.1000-7423.2026.04.009

• ORIGINAL ARTICLES • Previous Articles     Next Articles

Assessment of the risk of cyclosporiasis importation into China

XIA Shang1,2()(), XUE Jingbo1, HAO Yuwan1, LI Zhen1, TIAN Tian1, NI Haobo1, SHEN Yujuan1,2, ZHENG Bin1,2,*()(), LI Shizhu1,2,*()()   

  1. 1 National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention; Chinese Center for Tropical Diseases Research; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases; NHC Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases; National Center for International Research on Tropical Diseases, Ministry of Science and Technology, Shanghai 200025, China
    2 School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

Abstract:

Objective To systematically assess the risk of cyclosporiasis importation into China during multistage cyclosporiasis outbreaks in the United States in 2026, so as to provide insights into surveillance, early warning, and precision prevention and control of foodborne parasitic diseases. Methods A systematic search was conducted in Chinese and English databases as well as official websites of the United States Centers for Disease Control and Prevention and the United States Food and Drug Administration to collect data pertaining to the prevalence of Cyclospora infections, events of cyclosporiasis outbreaks, epidemiological investigations, and China import requirements for food products. The risk assessment matrix was employed to construct an indicator system for assessment of the risk of cyclosporiasis importation into China, and the likelihood of disease development and severity of consequences were comprehensively evaluated. Results Human Cyclospora infections have been reported across 54 countries in the world, with a pooled global prevalence rate of 3.4%. As of July 13, 2026, a total of 1 645 domestically acquired laboratory-confirmed cases had been reported in the United States. Evidence of human Cyclospora infections has been identified in nine provinces (municipalities) of China, with a pooled detection rate of 0.8% as revealed by PCR assay; however, no routine surveillance system has been established. The Kendall’s coefficients of concordance were 0.725 for likelihood of cyclosporiasis development (P < 0.001) and 0.796 for severity of consequences (P < 0.001), based on two rounds of expert consultations. Weighted scoring indicated that the likelihood of disease development was classified as Level C (possible) and the severity of consequences as Level 2 (minor). A comprehensive analysis with a risk assessment matrix revealed that the overall risk of cyclosporiasis importation into China was moderate. The risk associated with the specific implicated food chain was low, as Mexico-produced head lettuce lacked market access authorization for export to China and no relevant trade records were identified. By contrast, the risk associated with imported fresh produce and products sharing origins, suppliers, or processing links with United States markets was assessed as moderate to high. Conclusion The specific implicated food chain from the current United States outbreak poses a low risk of cyclosporiasis importation into China; however, there is a potential risk for shared-source contamination along global fresh produce supply chains, and China is not non-endemic for this disease. Dynamic surveillance of imported fresh produce and products linked to shared supply chains and improvements in domestic surveillance systems and supply chain traceability capacity are recommended.

Key words: Cyclosporiasis, Importation risk, Risk assessment, Foodborne parasitic disease

CLC Number: